Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 5 results for "genentech"

Mylan deal removes uncertainty over launch of Trastuzumab bios...

Global healthcare company Mylan has inked a settlement pack with Genentech and Roche in relation to patents for cancer drug Herceptin (Trastuzumab). Money Control, 2 months ago

58 images for genentech

BioPharma-Reporter.com, 3 months ago
Scrip Intelligence, 3 months ago
Pharma Live, 4 months ago
Cancer Therapy Advisor, 4 months ago
Scrip Intelligence, 4 months ago
Scrip Intelligence, 4 months ago
Xconomy, 4 months ago
Drug Development & Delivery, 4 months ago
Process and Control Today, 4 months ago
Nasdaq, 4 months ago
Reuters

Roche's Tecentriq wins FDA approval for treating advanced bladder cancer

Genentech, a unit of Swiss drugmaker Roche Holding AG, said on Monday it got approval from the U.S. Food and Drug Administration for its already approved immunotherapy drug, Tecentriq, to treat advanced bladder cancer. Tecentriq, also known as atezolizumab, ...
 Reuters1 month ago

CCI order against Roche is anti-competition: HC

The Delhi High Court on Wednesday termed as "anti-competition and anti-legal right", a Competition Commission of India's (CCI) order initiating an inquiry into the alleged abuse of dominant position by Swiss drug major Roche. Justice Sanjeev Sachdeva said the ...
 The Financial Chronicle5 days ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less